Compounds > n(6)-carboxymethyllysine
Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Lupus Erythematosus, Systemic

n(6)-carboxymethyllysine has been researched along with Lupus Erythematosus, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Blachut, D; Damasiewicz-Bodzek, A; Nowak, A; Nowalany-Kozielska, E; Przywara-Chowaniec, B; Tyrpień-Golder, K1
Bijl, M; Bijzet, J; de Leeuw, K; Graaff, R; Kallenberg, CG; Nienhuis, HL; Schalkwijk, CG; Smit, A1

Other Studies

2 other study(ies) available for n(6)-carboxymethyllysine and Lupus Erythematosus, Systemic

ArticleYear
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
    Cells, 2021, 12-13, Volume: 10, Issue:12

    Topics: Arginine; Female; Glycation End Products, Advanced; Humans; Lupus Erythematosus, Systemic; Lysine; Middle Aged; Receptor for Advanced Glycation End Products

2021
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:10

    Topics: Adult; Case-Control Studies; Female; Fluorescence; Glycation End Products, Advanced; Humans; Lupus Erythematosus, Systemic; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Skin; Vascular Cell Adhesion Molecule-1

2008